Sr. Computational Statistician at Eli Lilly and Company

Indianapolis, Indiana, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • Master’s degree in Statistics, Biostatistics or MSPH with concentration in Statistics or Biostatistics
  • Proficiency in statistical programming languages/software such as SAS, R, Spotfire, etc
  • Interpersonal/teamwork skills for effective interactions
  • Technical growth and application with solid understanding of statistics and statistical software
  • Self-management skills with a focus on results for prompt and accurate completion of competing deliverables
  • Creativity and innovation
  • Demonstrated problem solving ability and attention to detail
  • Data analysis, technology, and systems expertise

Responsibilities

  • Collaborate with other statistical colleagues and study personnel to provide input to statistical analysis plans, write reports and communicate results, assist/respond to regulatory queries
  • Assist in and/or be accountable for selecting statistical methods for data analysis, authoring the corresponding sections of the analysis plan, and conducting the actual analysis once a reporting database is created
  • Collaborate with data management in the planning and implementation of data quality assurance plans
  • Maintain proficiency with respect to SAS programming and statistical methodology and in applying new and varied methods
  • Effectively justify methods selected and implement previously outlined analysis plans
  • Conduct peer-review of work products from statistical colleagues
  • Effectively use current technologies and available tools for conducting the clinical trial analysis
  • Responsible for assisting in the communication of study results via regulatory submissions, and manuscripts, as well as for communicating one-on-one with key customers
  • Understand relevant disease states in order to enhance the level of customer focus and collaboration
  • Ensure replication of tools and systems, where applicable and stay informed of technological advances
  • Perform work in full compliance with assigned curriculum(s) and will be responsible for following applicable corporate, medical, local, and departmental policies, procedures, processes, and training

Skills

SAS
Statistical Analysis
Statistical Programming
Clinical Trials
Data Analysis
Data Quality Assurance
Regulatory Submissions
Statistical Methods

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI